Craig W. Philips - Net Worth and Insider Trading

Craig W. Philips Net Worth

The estimated net worth of Craig W. Philips is at least $779,795 dollars as of 2024-11-05. Craig W. Philips is the President of CTI BioPharma Corp and owns about 78,633 shares of CTI BioPharma Corp (CTIC) stock worth over $714,774. Craig W. Philips is also the President of Kineta Inc and owns about 95,465 shares of Kineta Inc (KANT) stock worth over $65,021. Details can be seen in Craig W. Philips's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig W. Philips has not made any transactions after 2023-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Craig W. Philips

To

Craig W. Philips Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Craig W. Philips owns 3 companies in total, including CTI BioPharma Corp (CTIC) , Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .

Click here to see the complete history of Craig W. Philips’s form 4 insider trades.

Insider Ownership Summary of Craig W. Philips

Ticker Comapny Transaction Date Type of Owner
CTIC CTI BioPharma Corp 2012-06-29 President
YMTX Yumanity Therapeutics Inc 2022-12-16 President
KANT Kineta Inc 2023-11-28 President

Craig W. Philips Latest Holdings Summary

Craig W. Philips currently owns a total of 2 stocks. Among these stocks, Craig W. Philips owns 78,633 shares of CTI BioPharma Corp (CTIC) as of June 29, 2012, with a value of $714,774 and a weighting of 91.66%. Craig W. Philips also owns 95,465 shares of Kineta Inc (KANT) as of November 28, 2023, with a value of $65,021 and a weighting of 8.34%.

Latest Holdings of Craig W. Philips

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTIC CTI BioPharma Corp 2012-06-29 78,633 9.09 714,774
KANT Kineta Inc 2023-11-28 95,465 0.68 65,021

Holding Weightings of Craig W. Philips


Craig W. Philips Form 4 Trading Tracker

According to the SEC Form 4 filings, Craig W. Philips has made a total of 0 transactions in CTI BioPharma Corp (CTIC) over the past 5 years. The most-recent trade in CTI BioPharma Corp is the sale of 1,840 shares on June 29, 2012, which brought Craig W. Philips around $52,440.

According to the SEC Form 4 filings, Craig W. Philips has made a total of 3 transactions in Kineta Inc (KANT) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Kineta Inc is the acquisition of 3,000 shares on November 28, 2023, which cost Craig W. Philips around $9,810.

Insider Trading History of Craig W. Philips

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Craig W. Philips Trading Performance

GuruFocus tracks the stock performance after each of Craig W. Philips's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig W. Philips is 14.16%. GuruFocus also compares Craig W. Philips's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig W. Philips within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Craig W. Philips's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Craig W. Philips

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 34.16 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 32.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Craig W. Philips Ownership Network

Ownership Network List of Craig W. Philips

No Data

Ownership Network Relation of Craig W. Philips

Insider Network Chart

Craig W. Philips Owned Company Details

What does CTI BioPharma Corp do?

Who are the key executives at CTI BioPharma Corp?

Craig W. Philips is the President of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .

CTI BioPharma Corp (CTIC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CTI BioPharma Corp Insider Transactions

No Available Data

Craig W. Philips Mailing Address

Above is the net worth, insider trading, and ownership report for Craig W. Philips. You might contact Craig W. Philips via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.